[HEARTS in Guatemala: Implementation experience in addressing cardiorenometabolic risk, 2022-2025HEARTS na Guatemala: experiência de implementação para abordar o risco cardiovascular, renal e metabólico, 2022-2025]. [PDF]
Alvarez-Nufio AI +3 more
europepmc +1 more source
Correlation between comfort and medication adherence in people with type 2 Diabetes Mellitus: a cross-sectional study. [PDF]
Lopes ROP +5 more
europepmc +1 more source
Management of Nocturnal Hypoglycaemia in a Patient with Type 2 Diabetes: The Role of Community Pharmacy. [PDF]
Nadal Domingo S +2 more
europepmc +1 more source
Continuous Insulin Infusion System and self-care in Type 1 Diabetes Mellitus: scope review. [PDF]
Brilhante RRDC +7 more
europepmc +1 more source
[Neutrophil-lymphocyte ratio and retinopathy in patients with type 2 diabetes mellitus]. [PDF]
Cuevas-Acuña MT +2 more
europepmc +1 more source
[Ischemic Priapism: evaluation in a third-level hospital in Mexico]. [PDF]
Sánchez-Villaseñor G +6 more
europepmc +1 more source
Tratamiento de la diabetes mellitus tipo 1: c?lulas madre
La Diabetes Mellitus (DM) es un conjunto de patolog?as metab?licas cr?nicas, que se caracteriza por una hiperglucemia causada por defectos en la secreci?n de insulina, en su acci?n o en ambos. Presenta una mayor prevalencia con los a?os y conlleva complicaciones a corto y largo plazo. La Diabetes Mellitus Tipo 1 (DMT1) est?
openaire +1 more source
[Compliance with drivers of the HEARTS-based integrated model for noncommunicable disease control in PeruNível de implementação dos fatores impulsionadores do modelo integrado para doenças não transmissíveis da iniciativa HEARTS no Peru]. [PDF]
Benites-Zapata V +3 more
europepmc +1 more source
[Diabetic neuropathy in patients with type 2 diabetes: the need for early diagnosis]. [PDF]
Campillo Piquer O, Lozano A.
europepmc +1 more source

